|
|
CORRECTION |
|
Year : 2017 | Volume
: 2
| Issue : 4 | Page : 163 |
|
Correction: VTI InterFuse® S vs. InterFuse® T for the treatment of scoliosis and degenerative disc disease: protocol for a multicenter post-market study
William F Lavelle1, Richard Tallarico1, Jeffrey C Felt M.D. 2
1 SUNY Upstate Medical University, East Syracuse, NY, USA 2 Vertebral Technologies, Inc., Minnetonka, MN, USA
Date of Web Publication | 5-Dec-2017 |
Correspondence Address: Jeffrey C Felt Vertebral Technologies, Inc., Minnetonka, MN USA
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/2542-4157.219379
How to cite this article: Lavelle WF, Tallarico R, Felt JC. Correction: VTI InterFuse® S vs. InterFuse® T for the treatment of scoliosis and degenerative disc disease: protocol for a multicenter post-market study. Clin Trials Orthop Disord 2017;2:163 |
How to cite this URL: Lavelle WF, Tallarico R, Felt JC. Correction: VTI InterFuse® S vs. InterFuse® T for the treatment of scoliosis and degenerative disc disease: protocol for a multicenter post-market study. Clin Trials Orthop Disord [serial online] 2017 [cited 2024 Mar 29];2:163. Available from: https://www.clinicalto.com/text.asp?2017/2/4/163/219379 |
The original version of this article contained a typographical error in the Abstract, which was incorrectly given as 18–19 years old. The correct age of patients should be 18 to 89 years old.
The online version of the original article can be found under doi: 10.4103/2542-4157.213687.[1]
References | | |
1. | Lavelle WF, Tallarico R, Felt JC. VTI InterFuse ® S vs. InterFuse ® T for the treatment of scoliosis and degenerative disc disease: protocol for a multicenter post-market study. Clin Trials Orthop Disord. 2017;2(3):104-112. |
|